Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen.
about
Stable isotope biomarker breath tests for human metabolic and infectious diseases: a review of recent patent literature.First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer.Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy.
P2860
Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Evaluation of CYP2D6 enzyme ac ...... receiving adjuvant tamoxifen.
@ast
Evaluation of CYP2D6 enzyme ac ...... receiving adjuvant tamoxifen.
@en
type
label
Evaluation of CYP2D6 enzyme ac ...... receiving adjuvant tamoxifen.
@ast
Evaluation of CYP2D6 enzyme ac ...... receiving adjuvant tamoxifen.
@en
prefLabel
Evaluation of CYP2D6 enzyme ac ...... receiving adjuvant tamoxifen.
@ast
Evaluation of CYP2D6 enzyme ac ...... receiving adjuvant tamoxifen.
@en
P2093
P2860
P1476
Evaluation of CYP2D6 enzyme ac ...... receiving adjuvant tamoxifen.
@en
P2093
Anil S Modak
David Rosen
Donald W Northfelt
James N Ingle
Joel M Reid
John L Black
Judith A Gilbert
Matthew L Kosel
Matthew M Ames
Matthew P Goetz
P2860
P304
P356
10.1097/FPC.0000000000000121
P577
2015-04-01T00:00:00Z